NorthStandard and Orca AI have entered an exclusive partnership that will see the global marine insurer encourage its members to adopt Orca AI’s market-leading automated situational awareness solution. Orca AI’s situational awareness platform is designed to ensure...
Latest News and Updates
ByHeart Announces $95M in New Financing On The Heels of Rapid Growth and the Completion of its End-to-End Manufacturing, Furthering its Commitment to Transforming the Infant Formula Industry
With the addition of two new production facilities in Oregon and Iowa, ByHeart is now positioned to triple its supply capacity to support families nationwide NEW YORK, May 13, 2024 /PRNewswire/ -- ByHeart, the next-generation infant nutrition company, today announced...
Rad AI Closes $50 Million to Empower Physicians with AI
Led by Khosla Ventures; investment to expand Rad AI’s generative AI solutions across health systems globally SAN FRANCISCO, May 7, 2024 /PRNewswire/ -- Rad AI, a leader in generative AI for healthcare, today announced it raised $50 million in Series B financing. The...
NorthStandard, Leading Maritime Insurer, Partners with Orca AI to Offer Safety Benefits of Situational Awareness Platform
NorthStandard and Orca AI have entered an exclusive partnership that will see the global marine insurer encourage its members to adopt Orca AI’s market-leading automated situational awareness solution. Orca AI’s situational awareness platform is designed to ensure...
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, as well as leadership from a distinguished set of industry veterans, including Executive Chairman Mark Alles, former...
TORL BioTherapeutics Launches with $158 Million Series B Financing to Advance Development of Novel Oncology Biologics
Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, as well as leadership from a distinguished set of industry veterans, including Executive Chairman Mark Alles, former...
ByHeart Acquires Additional Domestic Infant Formula Manufacturing Facility Tripling its Supply Capacity and Continuing to Fortify Formula Production in the U.S.
ByHeart is positioned to reliably and safely meet the needs of families across the country and fully reopen to customers in Q2 of 2023 with an eye toward retail expansion this year The acquisition and pending FDA registration of this manufacturing facility, together...
ByHeart To Acquire Packaging Company Cascadia Nutrition
Acquisition of Packaging Facility Will Complete ByHeart's Ownership of Its End-To-End Manufacturing Process With this Acquisition, ByHeart Will Establish the first New Dedicated Infant Formula Packaging Facility in the Country to Supply the U.S. market in Over 20...
Rad AI Completes Acquisition of Equium Intelligence, Further Enhancing Radiologist-Led Leadership Team
Radiologist innovators Bill Boonn and Woojin Kim among the talented Equium team joining Rad AI to further enhance Rad AI’s suite of radiology workflow applications SAN FRANCISCO, Calif., Nov 27, 2022 -- Rad AI and Equium Intelligence today announced the acquisition of...
Ossio Raises $38.5M Series C to fuel its growth in the orthopedic space
Ossio, a fast-growing orthopedic fixation technology company, announced today that it has closed $38.5 million in Series C financing. Along with the participation of OCV Partners, the round was led by MVM Partners, a Boston- and London-based growth equity firm...
ByHeart Announces the Launch of its Groundbreaking Infant Formula, Becoming the Only New Infant Formula Brand in Decades to Rewrite the Recipe From Scratch
After co-leading the $70M Series A alongside Polaris & D1 Capital and doubling down on the $90M Series B, OCV is incredibly proud to share that our portfolio company ByHeart is the first new infant formula manufacturer in over 15 years to be registered with FDA,...
Ockam Raises $12.5m Series A to Build a Remote-First, High-Performance Team
Ockam builds open-source developer-first tools for mutual authentication and end-to-end encrypted messaging between distributed applications, in any environment, anywhere… Trust Data-in-Motion. Ockam has secured $12.5 million of Series A funding from OCV,...
Rad AI Closes $25 Million Series A to Transform Radiology Workflow by Harnessing the Power of Artificial Intelligence
Rad AI, the fastest growing radiologist-led AI company, today announced $25 million in Series A funding. The round was led by Artis Ventures with participation from several existing investors, including OCV Partners, Kickstart Fund, and Gradient Ventures (Google's...
SafeBreach Closes $53.5 Million Series D in New Funding to Fuel Momentum
SafeBreach, the pioneer in breach and attack simulation, today announced that it has raised $53.5 million in Series D funding, led by Sonae IM and Israel Growth Partners (IGP), with additional participation from new investors Sands Capital and Leumi Partners, as well...
ByHeart, the First and Only Infant Formula Company in the US to Receive the Clean Label Project Purity Award
Congratulations to our portfolio company ByHeart on being the first and only infant formula company in the US to receive the “Clean Label Project Purity Award” certification from the Clean Label Project. The Clean Label Project screened ByHeart’s formula for over 500...
General Partner Chris Bostick Named One of Biocom California’s Ten Life Science Trailblazers Under 40 for 2021
OCV congratulates Dr. Chris Bostick on receiving the Biocom Life Science Catalyst Award. Chris is a General Partner at OCV Partners with over a decade of interdisciplinary research experience. Chris joined OCV in 2018 and has provided his expertise and leadership to...
OCV Promotes Dr. Chris Bostick to General Partner
OCV Partners (“OCV”) announced today that Dr. Chris Bostick has been promoted to General Partner. Chris joined OCV in 2018 and has provided his expertise and leadership to all of our healthcare investments as well as contributing to many of our non-healthcare...
ByHeart Secures $90M Series B Financing and Achieves All of its Clinical Trial Endpoints
ByHeart - the only new entrant to the US market to build its infant formula recipe entirely from scratch - achieves all of its clinical trial endpoints in the largest and most comprehensive clinical trial from a new infant formula brand in 25 years, further cementing...
With our decades of company building experience, we look to create asymmetric advantages when backing winning teams.